"The effect of 48-weeks azithromycin therapy on levels of soluble biomarkers associated with HIV-associated chronic lung disease" (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.intimp.2023.109756
PubMed Identifier: 36682262
Publication URI: http://europepmc.org/abstract/MED/36682262
Type: Journal Article/Review
Parent Publication: International Immunopharmacology
ISSN: 1567-5769